Search here...

Team Details

Nuclear Free World Foundation > Gabit Alipov

Gabit Alipov (born September 6, 1964) is an Kazakstan and Japan Medical Science, geneticist and oncologist.

Career Alipov earned degrees at the Department of Pathology Atomic Bomb Disease Institute Nagasaki University School of Medicine Nagasaki city in Japan (PhD Ms, 1999). After attending Institute worked а Lecturer in Department of Pathology, Atomic Bomb Disease Institute Nagasaki University School of Medicine Nagasaki city Japan from 2002 to 2005, From 2006, Alipov served as Chief of department cytopathology National Research Institute of Radiology and Oncology in Almaty, Kazakhstan. From 2006 to 2011 served as Chef of Department of Histopathology and Forensic Medicine Kazakh Medical University Almaty, Republic of Kazakhstan. For 10 years he held the position of Chief of Molecular Cytology Laboratory Medical center Sunkar, Republic of Kazakhstan. Currently holds the position of Chief of Department Cytology and Pathology Almaty Regional Oncology Hospital Almaty, Republic of Kazakhstan. 

Research activity

  1. General Pathological services: Department of Pathology, Atomic Bomb Disease Institute, Nagasaki University Hospital and related hospitals, Nagasaki, Japan
  2. Molecular Pathology in Gastrointestinal Carcinogenesis
  3. Late effect of irradiation in Atomic Bomb survivors (Hibakusha’s)
  4. Late effect of radiation fallout region Former Soviet Union Semipalatinsk Nuclear Testing site, Republic of Kazakhstan (cancer and radiation)
  5. Participated: Digestive Disease Week and the 96th annual meeting of the American Gastroenterological Association. San Francisco, California, May 19-22, 1996.
  6. Participated: Digestive Disease Week and the 100th annual meeting of the American Gastroenterological Association. Orlando, Florida, USA. May 16-19, 1999.
  7. Participated: Tokyo International Conference on Semipalatinsk nuclear test site 6-7 September 1999. First session: Priority needs and medical assistance to the affected population. Second session: Other major consequences and priorities for aid action
  8. Participated: The JICA Project for the Improvement of Health Care Services in Semipalatinsk Region July 1 2000- June 30 2005 years.
  9. Member of Japanese cancer association.
  10. Member of research project of cancer screening, department of Oncology Kazakh National Medical University, Kazakhstan.
  11. Member of State project earlier diagnosis of cancer patients and improvement of quality of life of patients diagnosed with oncology department of Oncology Kazakh National Medical University, Kazakhstan

Published

  1. Yoshiura KI, Kioshita A, Ishida T, Ninokata A, Ihikawa T, Kaname T, Bannai M, Tokunaga K, Sonoda S, Komaki R, Ihara M, Saenko VA, Alipov GK, Sekine I et. all SNP in the ABCC11 gene is the determinant of human earwax type Nat Genet 2006 Jan 29
  2. Alipov G, Nakayama T, Ito M, Kawai K, Naito S, Nakashima M, Niino D, Sekine I. Overexpression of Ets-1 proto-oncogene in latent and clinical prostatic carcinomas. Histopathology. 2005 Feb;46 (2):202-8.
  3. Alipov G, Nakayama T, Nakashima M, Wen CY, Niino D, Kondo H, Pruglo Y,　Sekine I. Epstein-Barr virus-associated gastric carcinoma in Kazakhstan. World J Gastroenterol. 2005 Jan 7;11(1):27-30.
  4. Alipov G, Ito M, Prouglo Y, Takamura N, Yamashita S. Ret proto-oncogene rearrangement in thyroid cancer around Semipalatinsk nuclear testing site. Lancet. 1999 Oct 30;354(9189):1528-9.
  5. Alipov GK, Ito M, Nakashima M, Ikeda Y, Nakayama T, Ohtsuru A, Yamashita S, Sekine I. Expression of parathyroid hormone-related peptide (PTHrP) in gastric tumours. J Pathol. 1997 Jun;182(2):174-9.
  6. Hamada A, Takamura N, Meirmanov S, Alipov G, Mine M, Ensebaev R, Sagandikova S, Ohashi T, Yamashita S. No evidence of radiation risk for thyroid gland among schoolchildren around Semipalatinsk Nuclear Testing Site. Endocr J. 2003 Feb;50(1):85-9.
  7. Ito M, Nakashima M, Alipov GK, Matsuzaki S, Ohtsuru A, Yano H, Yamashita S, Sekine I. Gastric cancer associated with overexpression of parathyroid hormone-related peptide (PTHrP) and PTH/PTHrP receptor in relation to tumor progression.J Gastroenterol 1997 Jun;32(3):396-400.
  8. Iwata K, Takamura N, Nakashima M, Alipov G, Mine M, Matsumoto N, Yoshiura K, Prouglo Y, Sekine I, Katayama I, Yamashita S. Loss of heterozygosity on chromosome 9q22.3 in microdissected basal cell carcinomas around the Semipalatinsk Nuclear Testing Site, Kazakhstan. Hum Pathol. 2004 Apr;35(4):460-4.
  9. Nakashima M, Ito M, Ohtsuru A, Alipov GK, Matsuzaki S, Nakayama T, Yamashita S, Sekine I. Expression of parathyroid hormone (PTH)-related peptide (PTHrP) and PTH/PTHrP receptor in giant cell tumour of tendon sheath. J Pathol. 1996 Sep;180(1):80-4.
  10. Shklyaev SS, Namba H, Mitsutake N, Alipov G, Nagayama Y, Maeda S, Ohtsuru A, Tsubouchi H, Yamashita S. Transient activation of c-Jun NH2-terminal kinase by growth factors influences survival but not apoptosis of human thyrocytes. Thyroid. 2001 Jul;11(7):629-36.
  11. Takamura N, Yamashita S, Namba H, Alipov G, Ito M, Sekine I, Espenbetova M, Raisov T, Gusev B. Need for investigation of thyroid disease around Semipalatinsk nuclear testing site, Kazakhstan. Thyroid. 1998 Jul;8(7):635-6.
  12. Nakayama T, Yoshizaki A, Naito S, Wen CY, Alipov GK, Yakata Y, Sekine I. Expression of Ets-1 proto-oncoprotein in gastrointestinal stromal tumors, leiomyomas and schwannomas. World Journal of Gastroenterology 2006 Mar 21;12(11):1743-1746.
  13. The Influence of Alpha-fetoprotein on Natural Suppressor Cell Activity and Ehrlich Carcinoma Growth. Belyaev NN, Bogdanov AY, Savvulidi PG, Krasnoshtanov VK, Tleulieva RT, Alipov GK, Sekine I, Bae JS, Lee JB, Min YK, Yang HM. Korean J Physiol Pharmacol. 2008 Aug;12(4):193-7. doi: 10.4196/kjpp.2008.12.4.193. Epub 2008 Aug 31.PMID: 19967055